You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PD-L1 Expression

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression = 1% and an STK11

Recruiting
  • Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation
  • Montpellier, France
  • +7 more
Dec 19, 2022

Head and Neck Squamous Cell Carcinoma, Magnetic Resonance Imaging, Neoadjuvant Therapy Trial in Guangzhou

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +2 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen Memorial Hospital
    Jul 27, 2023

    Breast Cancer Trial in Boston (Pembrolizumab, Nab-Paclitaxel, Biopsy)

    Active, not recruiting
    • Breast Cancer
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Aug 22, 2022

    DLBCL Trial (Sintilimab, Rituximab)

    Not yet recruiting
    • Diffuse Large B-Cell Lymphoma
    • (no location specified)
    Mar 6, 2022

    Esophageal Squamous Cell Carcinoma Trial in Wuhan (Intensity-modulated radiotherapy (IMRT), Tislelizumab, Cisplatin)

    Not yet recruiting
    • Esophageal Squamous Cell Carcinoma
    • Intensity-modulated radiotherapy (IMRT)
    • +3 more
    • Wuhan, Hubei, China
      Renmin hosptial of Wuhan University
    Jun 16, 2023

    Breast Cancer Trial in Tucson (Rucaparib)

    Active, not recruiting
    • Breast Cancer
    • Tucson, Arizona
      University of Arizona Cancer Center
    Feb 24, 2022

    PD-L1 Expression in Japanese Renal Cell Carcinoma Patients

    Completed
    • Renal Cell Carcinoma
      • Nagoya-city, Aichi, Japan
        Aichi Medical University
      Aug 26, 2021

      Programmed Death Ligand-1 in Nasopharyngeal and Hyypopharyngeal

      Not yet recruiting
      • Nasopharyngeal and Hypopharyngeal Carcinoma
      • immunohistochemical
      • Sohag, Egypt
        Sohag University Hospital
      Oct 23, 2022

      Non-squamous NSCLC, EGFR Gene Mutation Trial in Chengdu (Tislelizumab Combined With Bevacizumab and Platinum Plus Pemetrexed)

      Not yet recruiting
      • Non-squamous Non-small Cell Lung Cancer
      • EGFR Gene Mutation
      • Tislelizumab Combined With Bevacizumab and Platinum Plus Pemetrexed
      • Chengdu, Sichuan, China
      • +2 more
      May 24, 2022

      NSCLC Trial (fianlimab, cemiplimab, Pemetrexed)

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • (no location specified)
      Mar 23, 2023

      NSCLC Trial in London ([99mTc]-NM01 SPECT/CT)

      Not yet recruiting
      • Non-Small Cell Lung Cancer
      • [99mTc]-NM01 SPECT/CT
      • London, United Kingdom
        Guy's and St Thomas' NHS Foundation Trust
      Jul 29, 2021

      CTCs in HNSCC Patients Underwent Curative CCRT

      Recruiting
      • Head and Neck Squamous Cell Carcinoma
      • Circulating Tumor Cell
        • Taoyuan, Taiwan
          Chang Gung Memorial Hospital
        Aug 17, 2021

        Consistency of PD-L1 Detecting Method Between E1L3N and 22C3

        Completed
        • Non Small Cell Lung Cancer
          • Changsha, Hunan, China
            Hunan Cancer Hospital
          Nov 20, 2021

          Gastric Cancer, Peritoneal Carcinomatosis Trial in Chicago (Cisplatin, Mitomycin)

          Recruiting
          • Gastric Cancer
          • Peritoneal Carcinomatosis
          • Chicago, Illinois
            University of Chicago
          Jan 19, 2022

          SOX2 & PDL1 Expression on Urinary Bladder Carcinoma

          Not yet recruiting
          • Urinary Bladder Neoplasm
            • (no location specified)
            Jun 17, 2022

            PD-L1 in Pancreatic Ductal Adenocarcinoma

            Recruiting
            • Pancreatic Adenocarcinoma
              • Sohag, Egypt
                Faculty of Medicine, Sohag University
              Jan 27, 2022

              Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma Trial in Houston (other,

              Recruiting
              • Metastatic Head and Neck Squamous Cell Carcinoma
              • Recurrent Head and Neck Squamous Cell Carcinoma
              • Hafnium Oxide-containing Nanoparticles NBTXR3
              • +3 more
              • Houston, Texas
                M D Anderson Cancer Center
              Dec 5, 2022

              Patients With Advanced Urothelial Carcinoma

              Active, not recruiting
              • Urothelial Carcinoma
                • Los Angeles, California
                • +40 more
                Dec 7, 2022

                Locally Advanced or Metastatic Solid Tumors Irrespective of PD-L1 Expression Trial in Groningen (89Zr-MPDL-3280A-PET scans)

                Active, not recruiting
                • Locally Advanced or Metastatic Solid Tumors Irrespective of PD-L1 Expression
                • 89Zr-MPDL-3280A-PET scans
                • Groningen, Netherlands
                  University Medical Center Groningen
                Feb 28, 2022

                Metastatic Melanoma, Immune Checkpoints Inhibitors, Gastrointestinal Microbiome (Bacterial and Viral) Trial in Ljubljana (Immune

                Recruiting
                • Metastatic Melanoma
                • +3 more
                • Immune checkpoint inhibitor
                • Ljubljana, Slovenia
                  Institute of Oncology Ljubljana
                May 17, 2023

                NSCLC Stage IV Trial in Xiamen (Envafolimab)

                Active, not recruiting
                • Non-small Cell Lung Cancer Stage IV
                • Xiamen, Fujian, China
                  First affiliated Hospital of Xiamen University
                Sep 14, 2021

                Lung Cancer, Mesothelioma Trial in Orbassano (niraparib and dostarlimab)

                Recruiting
                • Lung Cancer
                • Mesothelioma
                • niraparib and dostarlimab
                • Orbassano, Turin, Italy
                  AOU San Luigi- Department of Oncology
                Oct 6, 2021

                Immune Infiltration in High-risk Non Muscle Invasive Bladder

                Completed
                • Bladder Cancer
                • Samples of bladder tissue
                • Talence, France
                  Centre Hospitalier Universitaire de Bordeaux
                Jan 25, 2021

                Lung Tumors Trial (Envafolimab, Endostar)

                Not yet recruiting
                • Lung Neoplasms
                • (no location specified)
                Feb 8, 2022

                Small Cell Lung Cancer (SCLC) Trial in New York (biological, drug, radiation)

                Terminated
                Has Results
                • Small Cell Lung Cancer (SCLC)
                • Pembrolizumab
                • +4 more
                • New York, New York
                  Laura and Isaac Perlmutter Cancer Center at NYU Langone
                Oct 18, 2021